Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Implementation of an adaptive group sequential design in a bioequivalence study.

Bandyopadhyay N, Dragalin V.

Pharm Stat. 2007 Apr-Jun;6(2):115-22.

PMID:
17436336
2.

Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors.

Oostendorp RL, Loftiss J, Goel S, Smith DA, Dar MM, Witteveen PO, Cohen RB, Lewis LD, Kurian S, Patnaik A, Rosing H, Beijnen JH, Voest EE, Burris H, J.

Int J Clin Pharmacol Ther. 2009 Mar;47(3):195-206.

PMID:
19281729
3.
4.
5.
7.

Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.

Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

PMID:
19302912
8.

Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.

Piñeyro-López A, Piñeyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez-Silva M, Waksman N, E Salazar-Leal M, Luján-Rangel R.

Clin Ther. 2007 Sep;29(9):2049-54.

PMID:
18035203
9.

Bioequivalence of two formulations of glucosamine sulfate 500-mg capsules in healthy male Chinese volunteers: an open-label, randomized-sequence, single-dose, fasting, two-way crossover study.

Zhu Y, Zou J, Xiao D, Fan H, Yu C, Zhang J, Yang J, Guo D.

Clin Ther. 2009 Jul;31(7):1551-8. doi: 10.1016/j.clinthera.2009.07.019.

PMID:
19695404
10.

Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.

Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS.

Clin Ther. 2009 May;31(5):1037-45. doi: 10.1016/j.clinthera.2009.05.001.

PMID:
19539104
12.

Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.

Di Girolamo G, Keller GA, de Los Santos AR, Schere D, Gonzalez CD.

Clin Ther. 2008 Nov;30(11):2015-23. doi: 10.1016/j.clinthera.2008.11.005.

PMID:
19108789
13.

Non-traditional study designs to demonstrate average bioequivalence for highly variable drug products.

Patterson SD, Zariffa NM, Montague TH, Howland K.

Eur J Clin Pharmacol. 2001 Nov;57(9):663-70.

PMID:
11791897
14.

Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.

Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG.

Clin Ther. 2009 Aug;31(8):1796-803. doi: 10.1016/j.clinthera.2009.08.004.

PMID:
19808138
15.
17.

Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers.

Fontes-Ribeiro C, Macedo T, Nunes T, Neta C, Vasconcelos T, Cerdeira R, Lima R, Rocha JF, Falcão A, Almeida L, Soares-da-Silva P.

Drugs R D. 2008;9(6):447-54. doi: 10.2165/0126839-200809060-00007.

PMID:
18989993
18.

Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers.

Mignini F, Streccioni V, Tomassoni D, Traini E, Amenta F.

Clin Exp Hypertens. 2007 Nov;29(8):575-86.

PMID:
18058482
19.

Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.

Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR.

Clin Ther. 2009 Apr;31(4):793-803. doi: 10.1016/j.clinthera.2009.04.017.

PMID:
19446152
20.

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.

Clin Ther. 2007 Jun;29(6):1146-52.

PMID:
17692728

Supplemental Content

Support Center